Market Place
Sourcing Support
All News #Library
Biotech
Psyence Biomed Approves Put Option Agreement With Psylabs
13 Feb 2026 //
GLOBENEWSWIRE
Psyence BioMed Launches Phase IIb Psilocybin Trial
19 Dec 2025 //
GLOBENEWSWIRE
Psyence Biomed Launches Psilocybin Longevity Research Program
25 Nov 2025 //
GLOBENEWSWIRE
Psyence Group Provides Update on Private Placement
25 Jun 2025 //
GLOBENEWSWIRE
Psyence Biomedical boosts board with Dr. Dan J. Stein
25 Mar 2025 //
GLOBENEWSWIRE
Psyence walks away from acquisition of fellow psilocybin biotech
07 Oct 2024 //
FIERCE BIOTECH
Psyence Group Enters into Agreement to Dispose of Stake in PsyLabs
20 Sep 2024 //
GLOBENEWSWIRE
Psyence Biomed Issues Progress And Milestones Update
18 Sep 2024 //
GLOBENEWSWIRE
Psyence Biomed Issues Update On Progress And Milestones
16 Sep 2024 //
GLOBENEWSWIRE
Psyence Biomedical Initiates Australian Trial Site
16 Sep 2024 //
GLOBENEWSWIRE
Psyence Biomedical Receives Nasdaq Delisting Determination
13 Sep 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.